Drugs / platelet rich fibrin matrix
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT03044119 Comparator | Mar 2018 → Jul 2019 | — | KLE Society's Institute of Dental Sciences | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | platelet rich fibrin matrix | “Platelet rich fibrin matrix (PRFM) is an autologous concentrated platelet-rich thrombin free fibrin matrix, prepared by two step centrifugation of blood.” NCT03044119 ↗ |
| Known as | PRFM | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03044119 ↗ |